Literature DB >> 2742838

Probing molecular polymorphism of fibronectins with antibodies directed to the alternatively spliced peptide segments.

K Sekiguchi1, K Titani.   

Abstract

Molecular heterogeneity of fibronectins (FNs) isolated from plasma, cultured fibroblasts, and placenta was studied with site-specific antibodies recognizing alternatively spliced peptide segments, termed ED-A and IIICS/delta 2. The antibodies were raised in rabbits by immunization with synthetic peptides. Neither the ED-A nor the IIICS/delta 2 extra peptide segment was present in the major subunits of plasma FN, although a minor subunit contained the latter extra segment. Cellular FN consisted of at least four subunits differing in size of the fragments generated by cleavage of the C-terminal region with cathepsin D. These fragments were distinct from each other in the reactivity with anti-ED-A and anti-IIICS/delta 2 antibodies, suggesting that all combinations of the presence or absence of the extra segments were produced by cultured fibroblasts. Placental FN was more heterogeneous than plasma and cellular FNs, consisting of five, or probably more, subunits. Among these, the two smaller subunits appeared to be closely similar to the major subunits of plasma FN, whereas the other subunits were more related to those of cellular FN in the size of cathepsin D cleaved C-terminal fragments and in the reactivity with anti-peptide antibodies. These results, taken together, indicate that the FNs produced by different tissues or cell types are distinct from each other in the number and types of subunits, which are partly, if not all, defined by alternative splicing at the ED-A and IIICS regions.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2742838     DOI: 10.1021/bi00434a026

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  5 in total

1.  Characterization of mouse fibronectin alternative mRNAs reveals an unusual isoform present transiently during liver development.

Authors:  G K Górski; M C Aros; P A Norton
Journal:  Gene Expr       Date:  1996

2.  Cell-type-specific expression of alternatively spliced human fibronectin IIICS mRNAs.

Authors:  R P Hershberger; L A Culp
Journal:  Mol Cell Biol       Date:  1990-02       Impact factor: 4.272

3.  VLA-4-fibronectin interaction is required for the terminal differentiation of human bone marrow cells capable of spontaneous and high rate immunoglobulin secretion.

Authors:  E Roldán; A García-Pardo; J A Brieva
Journal:  J Exp Med       Date:  1992-06-01       Impact factor: 14.307

4.  Selective secretion of alternatively spliced fibronectin variants.

Authors:  J E Schwarzbauer; C S Spencer; C L Wilson
Journal:  J Cell Biol       Date:  1989-12       Impact factor: 10.539

5.  Modulation of cell-adhesive activity of fibronectin by the alternatively spliced EDA segment.

Authors:  R Manabe; N Ohe; T Maeda; T Fukuda; K Sekiguchi
Journal:  J Cell Biol       Date:  1997-10-06       Impact factor: 10.539

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.